N
MCRB icon

Nuveen’s Seres Therapeutics MCRB Stock Holding History

Nuveen’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,974
Closed -$665K – 3337
2023
Q3 		$665K Sell
13,974
-73
-0.5% -$5.57K ﹤0.01% 2741
2023
Q2 		$1.35M Sell
14,047
-4,438
-24% -$483K ﹤0.01% 2522
2023
Q1 		$2.1M Buy
18,485
+3,266
+21% +$353K ﹤0.01% 2311
2022
Q4 		$1.71M Sell
15,219
-8,017
-35% -$1.07M ﹤0.01% 2462
2022
Q3 		$2.98M Buy
23,236
+12,993
+127% +$1.33M ﹤0.01% 2179
2022
Q2 		$702K Sell
10,243
-2,452
-19% -$211K ﹤0.01% 2929
2022
Q1 		$1.85M Buy
12,695
+653
+5% +$100K ﹤0.01% 2537
2021
Q4 		$1.92M Sell
12,042
-13,284
-52% -$2.11M ﹤0.01% 2580
2021
Q3 		$3.61M Buy
25,326
+11,158
+79% +$2.18M ﹤0.01% 2382
2021
Q2 		$1.31M Buy
14,168
+3,093
+28% +$1.31M ﹤0.01% 2897
2021
Q1 		$1.03M Sell
11,075
-92
-0.8% -$42.4K ﹤0.01% 2874
2020
Q4 		$1.04M Buy
11,167
+198
+2% +$116K ﹤0.01% 2792
2020
Q3 		$1.02M Sell
10,969
-1,933
-15% -$643K ﹤0.01% 2681
2020
Q2 		$1.23M Buy
12,902
+1,268
+11% +$111K ﹤0.01% 2539
2020
Q1 		$831K Sell
11,634
-818
-7% -$54.9K ﹤0.01% 2591
2019
Q4 		$859K Sell
12,452
-5,416
-30% -$402K ﹤0.01% 2739
2019
Q3 		$1.43M Buy
17,868
+13,716
+330% +$906K ﹤0.01% 2544
2019
Q2 		$267K Buy
+4,152
New +$394K ﹤0.01% 3132

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen's MCRB Position: Q4 2023 in Review

Nuveen sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 13,974 shares — an estimated $665K sold.

Nuveen first reported a position in MCRB in Q2 2019 and held it in 18 quarters. The position peaked at $3.61M in Q3 2021. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

  • Nuveen reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Nuveen sold 13,974 Seres Therapeutics shares in Q4 2023, an estimated $665K.
  • Nuveen first reported a position in Seres Therapeutics in Q2 2019 and held it in 18 quarters.
  • Nuveen's Seres Therapeutics position peaked at $3.61M in Q3 2021.
  • 102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.